The RESPIRE trials: Two phase III, randomized, multicentre, placebo-controlled trials of Ciprofloxacin Dry Powder for Inhalation (Ciprofloxacin DPI) in non-cystic fibrosis bronchiectasis-Reference-Cited by-同舟云学术

The RESPIRE trials: Two phase III, randomized, multicentre, placebo-controlled trials of Ciprofloxacin Dry Powder for Inhalation (Ciprofloxacin DPI) in non-cystic fibrosis bronchiectasis

Published:2017-07 Issue: Volume:58 Page:78-85
ISSN:1551-7144
Container-title:Contemporary Clinical Trials
language:en
Short-container-title:Contemporary Clinical Trials

Author:

Aksamit Timothy,Bandel Tiemo-Joerg,Criollo Margarita,De Soyza Anthony,Elborn J. Stuart,Operschall Elisabeth,Polverino Eva,Roth Katrin,Winthrop Kevin L.,Wilson Robert

Publisher

Elsevier BV

Subject

Pharmacology (medical),General Medicine

Reference43 articles.

1. British Thoracic Society guideline for non-CF bronchiectasis;Pasteur;Thorax,2010

2. Non-cystic fibrosis bronchiectasis;McDonnell;Q. J. Med.,2013

3. Non-cystic fibrosis bronchiectasis;McShane;Am. J. Respir. Crit. Care Med.,2013

4. Inflammation: a two-edged sword – the model of bronchiectasis;Cole;Eur. J. Respir. Dis. Suppl.,1986

5. Management of bronchiectasis in adults;Chalmers;Eur. Respir. J.,2015

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rethinking bronchiectasis as an inflammatory disease;The Lancet Respiratory Medicine;2024-07

2. The Efficacy and Safety of Inhaled Antibiotics for the Treatment of Bronchiectasis in Adults;CHEST;2024-07

3. Advancing the pipeline of cystic fibrosis clinical trials: a new roadmap with a global trial network perspective;The Lancet Respiratory Medicine;2023-10

4. Clinimetric Properties of Outcome Measures in Bronchiectasis;Annals of the American Thoracic Society;2023-05

5. Antibiotic Stewardship und chronische Lungenerkrankungen;Zeitschrift für Pneumologie;2022-10-14